Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Carglumic Acid, Atc A16aa05 for the Period 03/01/2023 - 02/28/2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Pipamperone, Atc N05ad05 for the Period 03/01/2023 - 02/28/2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Elbasvir Grazoprevir, Atc J05ap54 for the Period 03/01/2023 - 02/28/2025

Open House Original Discount Represent 2023-07 - Cobicisistat / Emtricitrabin / Tenofovi a Altoviid Go))

Open House Drug Rebate Contracts Dasatinib, Atc L01ea02

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for the Active Substance Erythropoietin Alpha, Atc B03xa01 for the Period 03/01/2023 - 02/28/2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Progesterone (Exclusively Dosage Form Vka), Atc G03da04 for the Period 03/01/2023 - 02/28/2025

Completion of Non-exclusive Drug Discounts According to § 130a (8) Sgb V by Means of a So-called Open-house Model to the Active Ingredient Dornase Alfa (atc Code According to Who: R05cb13)

Completion of Non-exclusive Drug Discounts According to § 130a (8) Sgb V by Means of a So-called Open-house Model to the Active Ingredient Piribedil (atc Code According to Who: N04bc08)

Open House Drug Discount Agreements Colecalciferol, Non Rx, only Products that can be Prescribed According to Annex 1 Am-Rl G-Ba, Atc A11cc05